Patent | Date |
---|
Suspension formulation comprising an insulinotropic peptide Grant 11,246,913 - Alessi , et al. February 15, 2 | 2022-02-15 |
Rapid Establishment And/or Termination Of Substantial Steady-state Drug Delivery App 20210236413 - Alessi; Thomas R. ;   et al. | 2021-08-05 |
THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1c App 20200397690 - Alessi; Thomas R. ;   et al. | 2020-12-24 |
Rapid establishment and/or termination of substantial steady-state drug delivery Grant 10,869,830 - Alessi , et al. December 22, 2 | 2020-12-22 |
THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1c App 20200360267 - Alessi; Thomas R. ;   et al. | 2020-11-19 |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c Grant 10,583,080 - Alessi , et al. | 2020-03-10 |
Method Of Manufacturing An Osmotic Delivery Device App 20200054717 - Alessi; Thomas R. ;   et al. | 2020-02-20 |
Osmotic delivery systems and piston assemblies for use therein Grant 10,527,170 - Alessi , et al. J | 2020-01-07 |
Devices, formulations, and methods for delivery of multiple beneficial agents Grant 10,441,528 - Alessi , et al. Oc | 2019-10-15 |
Method of manufacturing an osmotic delivery device Grant 10,363,287 - Alessi , et al. | 2019-07-30 |
Rapid Establishment And/or Termination Of Substantial Steady-state Drug Delivery App 20190105259 - Alessi; Thomas R. ;   et al. | 2019-04-11 |
Rapid establishment and/or termination of substantial steady-state drug delivery Grant 10,231,923 - Alessi , et al. | 2019-03-19 |
Devices, Formulations, And Methods For Delivery Of Multiple Beneficial Agents App 20180256492 - Alessi; Thomas R. ;   et al. | 2018-09-13 |
THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1c App 20180256491 - Alessi; Thomas R. ;   et al. | 2018-09-13 |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c Grant 9,889,085 - Alessi , et al. February 13, 2 | 2018-02-13 |
Osmotic Delivery Device Comprising An Insulinotropic Peptide And Uses Thereof App 20170368145 - Alessi; Thomas R ;   et al. | 2017-12-28 |
Osmotic delivery device comprising an insulinotropic peptide and uses thereof Grant 9,682,127 - Alessi , et al. June 20, 2 | 2017-06-20 |
Highly Concentrated Drug Particles, Formulations, Suspensions And Uses Thereof App 20170119854 - Alessi; Thomas R. ;   et al. | 2017-05-04 |
Devices, Formulations, And Methods For Delivery Of Multiple Beneficial Agents App 20170079906 - ALESSI; Thomas R. ;   et al. | 2017-03-23 |
Osmotic Delivery Device Comprising An Insulinotropic Peptide And Uses Thereof App 20170072022 - Alessi; Thomas R. ;   et al. | 2017-03-16 |
Devices, formulations, and methods for delivery of multiple beneficial agents Grant 9,572,889 - Alessi , et al. February 21, 2 | 2017-02-21 |
Rapid Establishment And/or Termination Of Substantial Steady-state Drug Delivery App 20160354305 - Alessi; Thomas R. ;   et al. | 2016-12-08 |
Highly Concentrated Drug Particles, Formulations, Suspensions And Uses Thereof App 20160022582 - ALESSI; Thomas R. ;   et al. | 2016-01-28 |
Osmotic Delivery Device Comprising An Insulinotropic Peptide And Uses Thereof App 20150258016 - Alessi; Thomas R. ;   et al. | 2015-09-17 |
Devices, Formulations, And Methods For Delivery Of Multiple Beneficial Agents App 20150111818 - Alessi; Thomas R. ;   et al. | 2015-04-23 |
Osmotic delivery comprising an insulinotropic peptide and uses thereof Grant 8,940,316 - Alessi , et al. January 27, 2 | 2015-01-27 |
Devices, formulations, and methods for delivery of multiple beneficial agents Grant 8,926,595 - Alessi , et al. January 6, 2 | 2015-01-06 |
Osmotic Delivery Systems and Piston Assemblies for Use Therein App 20140378900 - Alessi; Thomas R. ;   et al. | 2014-12-25 |
Osmotic delivery systems and piston assemblies for use therein Grant 8,801,700 - Alessi , et al. August 12, 2 | 2014-08-12 |
Devices, Formulations, and Methods for Delivery of Multiple Beneficial Agents App 20130090287 - Alessi; Thomas R. ;   et al. | 2013-04-11 |
Rapid Establishment and/or Termination of Substantial Steady-State Drug Delivery App 20130030417 - Alessi; Thomas R. ;   et al. | 2013-01-31 |
Devices, formulations, and methods for delivery of multiple beneficial agents Grant 8,343,140 - Alessi , et al. January 1, 2 | 2013-01-01 |
Highly Concentrated Drug Particles, Formulations, Suspensions And Uses Thereof App 20120289944 - Alessi; Thomas R. ;   et al. | 2012-11-15 |
Rapid establishment and/or termination of substantial steady-state drug delivery Grant 8,298,561 - Alessi , et al. October 30, 2 | 2012-10-30 |
Suspension formulations of insulinotropic peptides and uses thereof Grant 8,299,025 - Alessi , et al. October 30, 2 | 2012-10-30 |
Suspension formulations of insulinotropic peptides and uses thereof App 20120178687 - Alessi; Thomas R. ;   et al. | 2012-07-12 |
Osmotic delivery systems and piston assemblies for use therein App 20110166554 - Alessi; Thomas R. ;   et al. | 2011-07-07 |
Rapid establishment and/or termination of substantial steady-state drug delivery App 20110076317 - Alessi; Thomas R. ;   et al. | 2011-03-31 |
Osmotic delivery systems and piston assemblies for use therein Grant 7,879,028 - Alessi , et al. February 1, 2 | 2011-02-01 |
Osmotic delivery systems and piston assemblies for use therein App 20100185184 - Alessi; Thomas R. ;   et al. | 2010-07-22 |
Highly concentrated drug particles, formulations, suspensions and uses thereof App 20100092566 - Alessi; Thomas R. ;   et al. | 2010-04-15 |
Osmotic delivery systems and piston assemblies for use therein Grant 7,682,356 - Alessi , et al. March 23, 2 | 2010-03-23 |
Devices, formulations, and methods for delivery of multiple beneficial agents App 20090202608 - Alessi; Thomas R. ;   et al. | 2009-08-13 |
Suspension formulations of insulinotropic peptides and uses thereof App 20080260840 - Alessi; Thomas R. ;   et al. | 2008-10-23 |
Osmotic delivery systems and piston assemblies for use therein App 20080091176 - Alessi; Thomas R. ;   et al. | 2008-04-17 |
Method of mitigating the adverse effects of IL-2 App 20040242676 - Alessi, Thomas R. ;   et al. | 2004-12-02 |
Novel naphthalenylalkyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents Grant 4,897,405 - Alessi , et al. January 30, 1 | 1990-01-30 |
Novel benzyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents Grant 4,895,862 - Alessi , et al. January 23, 1 | 1990-01-23 |